{"mainPropery":{"diseaseId":9535,"diseaseName":"Familial cold autoinflammatory syndrome","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/9535/familial-cold-autoinflammatory-syndrome","synonyms":["FCAS","Familial polymorphous cold eruption","Familial cold urticaria"],"synonyms-with-source":[{"name":"FCAS"},{"name":"Familial polymorphous cold eruption"},{"name":"Familial cold urticaria"}],"identifiers":[{"identifierType":"OMIM","identifierId":"120100"},{"identifierType":"ORPHANET","identifierId":"47045"},{"identifierType":"UMLS","identifierId":"C0343068"}]},"diseaseCategories":[{"diseaseTypeId":5,"diseaseTypeName":"Congenital and Genetic Diseases","source":"Orphanet"},{"diseaseTypeId":13,"diseaseTypeName":"Immune System Diseases","source":"Orphanet"},{"diseaseTypeId":15,"diseaseTypeName":"Musculoskeletal Diseases","source":"Orphanet"},{"diseaseTypeId":22,"diseaseTypeName":"Skin Diseases","source":"Orphanet"}],"organizations":[{"resourceID":933,"resourceName":"American Autoimmune Related Diseases Association","abbreviation":"AARDA","address1":"19176 Hall Road, Suite 130","address2":"","address3":"","address4":"","address5":"","city":"Clinton Township","state":"MI","zip":"48038","country":"United States","phone":"586-776-3900","tty":"","tollFree":"800-598-4668","fax":"586-776-3903","email":"aarda@aarda.org","url":"https://www.aarda.org/","freeText":""},{"resourceID":3600,"resourceName":"FMF & AID Global Association","abbreviation":"","address1":"Schüracherstrasse 25a","address2":"8306 Brüttisellen","address3":"","address4":"","address5":"","city":"","state":"","zip":"","country":"Switzerland","phone":"+41 76 415 4010","tty":"","tollFree":"","fax":"","email":"info@fmfandaid.org ","url":"https://www.fmfandaid.org/","freeText":""}],"resource descriptions":[{"id":7,"resourceId":10,"resourceName":"Online Mendelian Inheritance in Man (OMIM)","descriptionText":"<a href='http://www.omim.org/120100' target='_blank'>Online Mendelian Inheritance in Man (OMIM)</a> is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=DetailsSearch&Term=familial+cold+autoinflammatory+syndrome%5Bti%5D+OR+familial+cold+auto-inflammatory+syndrome%5Bti%5D+OR+familial+cold+urticaria%5Bti%5D' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Familial cold autoinflammatory syndrome. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":9,"resourceId":12,"resourceName":"ClinicalTrials.gov","descriptionText":"<a href='http://www.clinicaltrials.gov/ct2/results?cond=%22Familial+cold+autoinflammatory+syndrome%22' target='_blank'>ClinicalTrials.gov</a> lists trials that are related to Familial cold autoinflammatory syndrome. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. <br />\r\n<br />\r\n<em><strong>Please note:</strong>&nbsp;Studies listed on the&nbsp;ClinicalTrials.gov&nbsp;website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.</em>","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":10,"resourceId":13,"resourceName":"MedlinePlus Genetics","descriptionText":"<a href='http://ghr.nlm.nih.gov/condition=familialcoldautoinflammatorysyndrome' target='_blank'>Genetics Home Reference (GHR)</a> contains information on Familial cold autoinflammatory syndrome. This website is maintained by the National Library of Medicine.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":336,"resourceId":1154,"resourceName":"RareConnect","descriptionText":"<div style=\"margin-top: 0px; margin-bottom: 0px;\"><a href='https://www.rareconnect.org/en/community/caps' target='_blank'>RareConnect</a> has an online community for patients&nbsp;and families with this condition so they can connect with others and share&nbsp;their experiences living with a rare disease.&nbsp;The project is a joint collaboration between EURORDIS (European Rare Disease Organisation) and NORD (National Organization for Rare Disorders).</div>","resourceClassificationName":"Organizations","resourceClassificationSectionName":"Social Networking Websites"},{"id":720,"resourceId":1415,"resourceName":"Cryopyrin-Associated Periodic Syndromes_ full text article","descriptionText":"Leigh D Church, Sinisa Savic, and Michael F McDermott; <em><a href='http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&amp;pubmedid=19707454 ' target='_blank'>Long term management of patients with cryopyrin-associated periodic syndromes (CAPS): focus on rilonacept (IL-1 Trap), </a></em>Biologics. <span class=\"citation-publication-date\">2008 December; </span><span class=\"citation-volume\">2</span><span class=\"citation-issue\">(4)</span><span class=\"citation-flpages\">: 733–742.</span>","resourceClassificationName":"Overview","resourceClassificationSectionName":"Selected Full-Text Journal Articles"},{"id":1254,"resourceId":1919,"resourceName":"Cleveland Clinic-Periodic Fever Syndrome","descriptionText":"<a href='https://my.clevelandclinic.org/health/articles/17354-periodic-fever-syndrome' target='_blank'>The Cleveland Clinic</a> provides an overview of the different types of periodic fever syndromes.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1457,"resourceId":2104,"resourceName":"Genetic Services","descriptionText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the <a href='http://www.acmg.net/ACMG/Genetic_Services_Directory_Search.aspx' target='_blank'>American College of Medical Genetics</a> and the&nbsp;<a href='https://www.findageneticcounselor.com/' target='_blank'>National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also&nbsp;<a href='https://ghr.nlm.nih.gov/primer#consult' target='_blank'>learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1526,"resourceId":2158,"resourceName":"Genetic Testing Registry","descriptionText":"The <a href='http://www.ncbi.nlm.nih.gov/gtr/conditions/C0343068' target='_blank'>Genetic Testing Registry</a> (GTR) provides information about the genetic tests for this condition. The intended audience for the GTR is health care providers and researchers. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.<br />\r\n","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Testing Resources"},{"id":1527,"resourceId":2159,"resourceName":"National Organization for Rare Disorders","descriptionText":"The <a href='https://rarediseases.org/rare-diseases/familial-cold-autoinflammatory-syndrome/' target='_blank'>National Organization for Rare Disorders</a> (NORD) has a report for patients and families about this condition. NORD is a patient advocacy organization for individuals with rare diseases and the organizations that serve them.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1531,"resourceId":2162,"resourceName":"Medscape Reference","descriptionText":"<a href='http://www.emedicine.com/ped/topic3092.htm' target='_blank'>Medscape Reference</a> provides information on this topic. You may need to register to view the medical textbook, but registration is free.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=47045' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1550,"resourceId":2178,"resourceName":"DermNet New Zealand","descriptionText":"<a href='http://dermnetnz.org/systemic/fcas.html' target='_blank'>DermNet NZ</a> is an online resource about skin diseases developed by the New Zealand Dermatological Society Incorporated. DermNet NZ provides information about this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/DC:0000146' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2151,"resourceId":3359,"resourceName":"NIH study  familial cold autoinflammatory syndrome","descriptionText":"The National Institute of Allergy and Infectious Diseases (NIAID) study, <a target=\"_blank\" href=\"http://clinicalstudies.info.nih.gov/cgi/wais/bold032001.pl?A_09-I-0126.html@itch@@@@\">Pathogenesis of Physical Induced Urticarial Syndromes</a> is currently recruiting participants. The study aims to investigate mechanisms that may cause physical hives or urticaria and to reproduce urticaria through challenge testing (procedures to test the skin for a reaction to a stimulus), followed by mast cell studies, measurement of IL-1, genetic studies, and other molecular studies to lead to a better understanding of urticaria and to design safe and more effective treatments.","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":2722,"resourceId":4053,"resourceName":"Patient Registry","descriptionText":"A registry supports research by collecting of information about patients that share something in common, such as being diagnosed with Familial cold autoinflammatory syndrome. The type of data collected can vary from registry to registry and is based on the goals and purpose of that registry. Some registries collect contact information while others collect more detailed medical information. <a href=\"https://www.nih.gov/health-information/nih-clinical-research-trials-you/list-registries\" target=\"_blank\">Learn more about registries</a>.<br />\r\n<br />\r\nRegistries for&nbsp;Familial cold autoinflammatory syndrome:<br />\r\n<a href='https://usidnet.org/about-the-registry/patient-participation/' target='_blank'>United States Immunodeficiency Network (USIDENT) Registry</a><br />&nbsp;","resourceClassificationName":"Research","resourceClassificationSectionName":"Patient Registry"}],"overviewQuestion":{"questionId":730,"questionText":"What is familial cold autoinflammatory syndrome?","answerText":"<strong>Familial cold autoinflammatory syndrome</strong> is a type of <a href=\"http://my.clevelandclinic.org/disorders/periodic_fever_syndrome/rheumatology_overview.aspx\" target=_blank>periodic fever syndrome</a>. Signs and symptoms may include include an itchy or burning rash; fever; and joint pain which are triggered by exposure to cold temperatures. It is inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002049.htm\" target=_blank>autosomal dominant</a> manner and can be caused by <a href=\"http://ghr.nlm.nih.gov/handbook/mutationsanddisorders/genemutation\" target=_blank>mutations</a> in the <a href=\"http://ghr.nlm.nih.gov/gene=nlrp3\" target=_blank><em>NLRP3</em></a> or <a href=\"http://ghr.nlm.nih.gov/gene=nlrp12\" target=_blank><em>NLRP12</em></a> genes. Management of this condition involves avoiding exposure to cold temperatures and treatment with specific types of medications.[480][6297]","dateModified":"2013-10-30T15:10:00"},"basicQuestions":[{"questionId":733,"questionText":"What are the signs and symptoms of familial cold autoinflammatory syndrome?","answerText":"Signs and symptoms of familial cold autoinflammatory syndrome may include rash, fever, and joint pain triggered by exposure to cold temperatures. The rash often begins on exposed arms and legs and extends to the remainder of the body. The rash may consist of red <a href=\"http://www2.merriam-webster.com/cgi-bin/mwmednlm?book=Medical&amp;va=macules\" target=\"_blank\">macules</a> and <a href=\"http://www2.merriam-webster.com/cgi-bin/mwmednlm?book=Medical&amp;va=plaque\" target=\"_blank\">plaques</a>, hives (urticaria), and <a href=\"http://www2.merriam-webster.com/cgi-bin/mwmednlm?book=Medical&amp;va=petechiae\" target=\"_blank\">petechiae</a>. The skin rash can cause burning or itching. <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/001031.htm\" target=\"_blank\">Conjuctivitis</a> during a fever episode is also common. Other symptoms can include swelling, muscle pain, profuse sweating, drowsiness, headache, extreme thirst, and nausea.[480]\r\n<p>Symptoms may begin anywhere between 10 minutes to 8 hours after cold exposure. Fever attacks may last a few hours up to three days. Most people with familial cold autoinflammatory syndrome experience their first fever attack within the first year of life, many within the first day of life. Episodes continue to occur throughout life.[480]</p>","dateModified":"2013-11-01T10:41:00","resourceClassificationName":"Symptoms","references":[{"referenceId":480,"authors":"Simon A, Van Der Meer S, Drenth J","articleTitle":"Familial autoinflammatory syndromes","bookWebsiteJournalTitle":"Harris: Kelley's Textbook of Rheumatology, 7th ed","date":"2005","authors2":"Harris et al.,","placeOfPublication":"Philadelphia, PA","publisher":"Saunders"}]},{"questionId":732,"questionText":"What causes familial cold autoinflammatory syndrome?","answerText":"Familial cold autoinflammatory syndrome is caused by changes (<a href=\"http://www.genome.gov/glossary/index.cfm?id=134\" target=\"_blank\">mutations</a>) in either one of two genes: <a href=\"http://ghr.nlm.nih.gov/gene/NLRP3\" target=\"_blank\"><em>NLRP3</em></a> or <a href=\"http://ghr.nlm.nih.gov/gene/NLRP12\" target=\"_blank\"><em>NLRP12</em></a>. These genes normally provide instructions for making proteins involved in the immune system, helping to regulate the process of inflammation. Changes in these genes impair the body's mechanisms for controlling inflammation, resulting in the signs and symptoms of this condition. It remains unclear why episodes are triggered by cold exposure.[6297]","dateModified":"2013-11-01T10:42:00","resourceClassificationName":"Cause","references":[{"referenceId":1645,"authors":"","articleTitle":"Familial cold autoinflammatory syndrome","bookWebsiteJournalTitle":"Genetics Home Reference","date":"September 2008","url":"http://ghr.nlm.nih.gov/condition=familialcoldautoinflammatorysyndrome"}]},{"questionId":731,"questionText":"How is familial cold autoinflammatory syndrome inherited?","answerText":"Familial cold autoinflammatory syndrome is inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002049.htm\" target=\"_blank\">autosomal dominant</a> manner.[6297] This means that a mutation in only one of the two copies of the responsible gene is sufficient to cause signs and symptoms of the condition. When an individual with an autosomal dominant condition has children, each child has a 50% (1 in 2) risk to inherit the mutated copy of the gene. This also means that each child has a 50% risk to not inherit the mutated copy of the gene and therefore be unaffected.<br />\r\n<br />\r\nThere have been reported cases of this condition occurring in individuals with no history of the condition in the family; in these cases, the condition was not inherited from a parent, but occurred for the first time in the affected individual.[480]<br />","dateModified":"2013-11-01T10:40:00","resourceClassificationName":"Inheritance","references":[{"referenceId":480,"authors":"Simon A, Van Der Meer S, Drenth J","articleTitle":"Familial autoinflammatory syndromes","bookWebsiteJournalTitle":"Harris: Kelley's Textbook of Rheumatology, 7th ed","date":"2005","authors2":"Harris et al.,","placeOfPublication":"Philadelphia, PA","publisher":"Saunders"},{"referenceId":6297,"authors":"","articleTitle":"Familial cold autoinflammatory syndrome","bookWebsiteJournalTitle":"Genetics Home Reference","date":"September 2008","url":"http://ghr.nlm.nih.gov/condition/familial-cold-autoinflammatory-syndrome","dateAccessed":"2013-10-28T00:00:00"}]},{"questionId":736,"questionText":"How is familial cold autoinflammatory syndrome diagnosed?","answerText":"Familial cold autoinflammatory syndrome (FCAS) is primarily a clinical diagnosis, meaning that it is mostly based on the presence or absence of specific of signs and symptoms as well as family history.[6312] Diagnostic criteria have been proposed in order to distinguish FCAS from acquired cold urticaria and other periodic fever disorders. The criteria include: recurring episodes of fever and rash that primarily follow cold exposures; <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002049.htm\" target=\"_blank\">autosomal dominant</a> pattern of disease inheritance in a family; age of onset younger than 6 months; duration of most attacks less than 24 hours; <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/001031.htm\" target=\"_blank\">conjunctivitis</a> in association with attacks; and absence of deafness, swelling around the eyes, enlarged lymph nodes, and <a href=\"http://www2.merriam-webster.com/cgi-bin/mwmednlm?book=Medical&amp;va=serositis\" target=\"_blank\">serositis</a>.[480][6312] Having four of six of the criteria strongly suggests a diagnosis of FCAS. A diagnosis of FCAS may also be confirmed in some affected individuals by genetic testing.[6312]<br />","dateModified":"2013-11-01T10:43:00","resourceClassificationName":"Diagnosis","references":[{"referenceId":480,"authors":"Simon A, Van Der Meer S, Drenth J","articleTitle":"Familial autoinflammatory syndromes","bookWebsiteJournalTitle":"Harris: Kelley's Textbook of Rheumatology, 7th ed","date":"2005","authors2":"Harris et al.,","placeOfPublication":"Philadelphia, PA","publisher":"Saunders"},{"referenceId":6312,"authors":"Hoffman HM","articleTitle":"Familial Cold Autoinflammatory Syndrome","bookWebsiteJournalTitle":"Orphanet Encyclopedia","date":"February 2005","volume":"","pages":"","url":"https://www.orpha.net/data/patho/GB/uk-FCAS.pdf","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":735,"questionText":"How might familial cold autoinflammatory syndrome be treated?","answerText":"Individuals with familial cold autoinflammatory syndrome (FCAS) are generally advised to avoid exposure to cold temperatures. Bed rest, warmth and <a href=\"http://www.nlm.nih.gov/medlineplus/steroids.html\" target=\"_blank\">corticosteroids</a> can be used to treat an acute attack.[6313] Treatment may include the use of <a href=\"http://www.dermnetnz.org/treatments/biologics.html\" target=\"_blank\">biologic agents</a> (drugs derived from living material) which can control the symptoms of FCAS by blocking <a href=\"http://www.cancer.gov/dictionary?cdrid=350231\" target=\"_blank\">interleukin-1</a>; they are called selective recombinant interleukin-1 receptor agonists. Examples of these agents are rilonacept, <a href=\"http://www.nlm.nih.gov/medlineplus/druginfo/meds/a602001.html\" target=\"_blank\">anakinra</a>, and canakinumab.[6207][6313] These agents reportedly have a significant beneficial effect on quality of life for individuals with FCAS.[6313]","dateModified":"2013-11-14T15:25:00","resourceClassificationName":"Treatment","references":[{"referenceId":6207,"authors":"Marwan Shinawi","articleTitle":"Hereditary Periodic Fever Syndromes","bookWebsiteJournalTitle":"Medscape Reference","date":"January 11, 2013","volume":"","pages":"","url":"http://emedicine.medscape.com/article/952254-overview#aw2aab6b7","dateAccessed":"2016-12-12T00:00:00","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":6313,"authors":"Delwyn Dyall-Smith","articleTitle":"Familial cold autoinflammatory syndrome","bookWebsiteJournalTitle":"DermNet NZ","date":"March 2011","url":"http://www.dermnetnz.org/systemic/fcas.html","dateAccessed":"2013-10-30T00:00:00"}]},{"questionId":734,"questionText":"What is the long-term outlook for familial cold autoinflammatory syndrome?<br />","answerText":"Symptoms of familial cold autoinflammatory syndrome continue throughout one's lifetime, but may improve with treatment. Rare complications that have been reported in individuals  with this disorder include <a href=\"https://rarediseases.org/rare-diseases/amyloidosis/\" target=\"_blank\">amyloidosis</a> and <a href=\"https://medlineplus.gov/kidneyfailure.html\" target=\"_blank\">kidney failure</a>.[480][6207] &nbsp;","dateModified":"2016-12-12T00:00:00","resourceClassificationName":"Prognosis","references":[{"referenceId":480,"authors":"Simon A, Van Der Meer S, Drenth J","articleTitle":"Familial autoinflammatory syndromes","bookWebsiteJournalTitle":"Harris: Kelley's Textbook of Rheumatology, 7th ed","date":"2005","authors2":"Harris et al.,","placeOfPublication":"Philadelphia, PA","publisher":"Saunders"},{"referenceId":6207,"authors":"Marwan Shinawi","articleTitle":"Hereditary Periodic Fever Syndromes","bookWebsiteJournalTitle":"Medscape Reference","date":"January 11, 2013","volume":"","pages":"","url":"http://emedicine.medscape.com/article/952254-overview#aw2aab6b7","dateAccessed":"2016-12-12T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]}],"references":[],"relatedDiseases":[],"gardCases":[{"caseId":42039,"abbreviatedInquiry":"I have the syndrome, as did my mother, my second brother, and his oldest son. I had biopsies taken of the so-called hives and were told that they were neutrophiles from the blood. Is it common to have so many in one family to have this syndrome? Also, how often does it skip a generation?","caseQuestions":[{"questionId":731,"questionText":"How is familial cold autoinflammatory syndrome inherited?","answerText":"Familial cold autoinflammatory syndrome is inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002049.htm\" target=\"_blank\">autosomal dominant</a> manner.[6297] This means that a mutation in only one of the two copies of the responsible gene is sufficient to cause signs and symptoms of the condition. When an individual with an autosomal dominant condition has children, each child has a 50% (1 in 2) risk to inherit the mutated copy of the gene. This also means that each child has a 50% risk to not inherit the mutated copy of the gene and therefore be unaffected.<br />\r\n<br />\r\nThere have been reported cases of this condition occurring in individuals with no history of the condition in the family; in these cases, the condition was not inherited from a parent, but occurred for the first time in the affected individual.[480]<br />","dateModified":"2013-11-01T10:40:00","resourceClassificationName":"Inheritance","references":[{"referenceId":480,"authors":"Simon A, Van Der Meer S, Drenth J","articleTitle":"Familial autoinflammatory syndromes","bookWebsiteJournalTitle":"Harris: Kelley's Textbook of Rheumatology, 7th ed","date":"2005","authors2":"Harris et al.,","placeOfPublication":"Philadelphia, PA","publisher":"Saunders"},{"referenceId":6297,"authors":"","articleTitle":"Familial cold autoinflammatory syndrome","bookWebsiteJournalTitle":"Genetics Home Reference","date":"September 2008","url":"http://ghr.nlm.nih.gov/condition/familial-cold-autoinflammatory-syndrome","dateAccessed":"2013-10-28T00:00:00"}]},{"questionId":7114,"questionText":"Is it common for several individuals in a family to have familial cold autoinflammatory syndrome? Can it skip a generation?","answerText":"Familial cold autoinflammatory syndrome (FCAS) is a rare condition, but because it is genetic and is inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002049.htm\" target=_blank>autosomal dominant</a> manner, it can affect many individuals within a family. Each child of an individual with FCAS has a 50% (1 in 2) risk to inherit the mutated (changed) copy of the responsible gene from the affected parent. This also means that each sibling of an individual with an affected parent has a 50% risk to inherit the mutated copy of the gene.<br><br>There have been reports of individuals inheriting the disease-causing mutation from an affected parent and not having any symptoms of FCAS.[6314] This is called <a href=\"http://ghr.nlm.nih.gov/handbook/inheritance/penetranceexpressivity\" target=_blank>reduced penetrance</a>. In autosomal dominant conditions with reduced penetrance, the condition may appear to \"skip a generation.\" Genetic testing may help determine whether an unaffected individual did not inherit he mutation, or did inherit the mutation but does not have any symptoms. An individual with a mutation who does not have symptoms still has a 50% risk to pass the mutation on to each child.","dateModified":"2013-10-30T15:02:00","references":[{"referenceId":6314,"authors":"Aróstegui JI et al","articleTitle":"Clinical and genetic heterogeneity among Spanish patients with recurrent autoinflammatory syndromes associated with the CIAS1/PYPAF1/NALP3 gene","bookWebsiteJournalTitle":"Arthritis Rheum","date":"December 2004","volume":"50(12)","pages":"4045-4050"}]}]}],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":5670,"phenoTypeName":"Arthritis","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":15301,"phenoTypeName":"Dysesthesia","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":11167,"phenoTypeName":"Erythema","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":13704,"phenoTypeName":"Fatigue","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":13043,"phenoTypeName":"Fever","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":8263,"phenoTypeName":"Hyperhidrosis","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":3980,"phenoTypeName":"Myalgia","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":8271,"phenoTypeName":"Pruritus","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":8303,"phenoTypeName":"Urticaria","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":11409,"phenoTypeName":"Headache","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13403,"phenoTypeName":"Nausea and vomiting","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13419,"phenoTypeName":"Abdominal pain","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":7919,"phenoTypeName":"Arthralgia","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":5616,"phenoTypeName":"Conjunctivitis","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13042,"phenoTypeName":"Dehydration","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13061,"phenoTypeName":"Polydipsia","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":11337,"phenoTypeName":"Sensorineural hearing impairment","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":3325,"phenoTypeName":"Aphthous ulcer","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":14045,"phenoTypeName":"Elevated C-reactive protein level","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":15555,"phenoTypeName":"Renal amyloidosis","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":9144,"phenoTypeName":"Uveitis","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":6539,"phenoTypeName":"Autosomal dominant inheritance","percentRanges":"-"},{"phenoTypeId":5374,"phenoTypeName":"Chills","percentRanges":"-"},{"phenoTypeId":6245,"phenoTypeName":"Infantile onset","percentRanges":"-"},{"phenoTypeId":13075,"phenoTypeName":"Leukocytosis","percentRanges":"-"},{"phenoTypeId":13054,"phenoTypeName":"Recurrent fever","percentRanges":"-"},{"phenoTypeId":8270,"phenoTypeName":"Skin rash","percentRanges":"-"}],"medicalProducts":[{"productId":404,"genericName":"Rilonacept","tradeName":"Arcalyst","tradeLink":"https://www.arcalyst.com/","manufacturer":"","sponsor":"Regeneron Pharmaceuticals, Inc.","indication":"February 2008, rilonacept (Arcalyst) was approved for treatment of cryopyrin-assisted periodic syndromes (CAPS).","drugInformationLink":"https://druginfo.nlm.nih.gov/drugportal/name/arcalyst","medlinePlusLink":""},{"productId":499,"genericName":"Canakinumab","tradeName":"Ilaris","tradeLink":"http://ilaris.com/index.jsp","manufacturer":"","sponsor":"Novartis Pharmaceuticals Corporation","indication":"June 2009, canakinumab (Ilaris) was approved for the treatment of cryopyrin-associated periodic syndromes (CAPS), in adults and children 4 years of age and older. In May 2013, it was also approved for the treatment of active Systemic Juvenile Idiopathic Arthritis (SJIA) in patients aged 2 through 16 years.","drugInformationLink":"https://druginfo.nlm.nih.gov/drugportal/name/ilaris","medlinePlusLink":""}],"EncodedName":"Familial_cold_autoinflammatory_syndrome"}